Quest PharmaTech Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Canada.
P/E ratio
0.7Investors pay 0.7 for every 1 of Quest PharmaTech Inc.'s yearly profit, lower than 98% of Healthcare companies in Canada.
P/B ratio
0.13The share price is 0.13 times Quest PharmaTech Inc.'s book value per share, lower than almost all Healthcare companies in Canada.
Market cap
C$3 MThe total market value of all of Quest PharmaTech Inc.'s shares at today's price (share price × number of shares), smaller than 84% of Healthcare companies in Canada. PosiCap size class: Nano Cap.
Return on equity (ROE)
20.0%Quest PharmaTech Inc. earned 20.0% on its shareholders' money over the last year, higher than 87% of Healthcare companies in Canada.
Dividend yield
NoneQuest PharmaTech Inc. does not currently pay a dividend.
Questions
What is Quest PharmaTech Inc.'s P/E ratio?
Investors pay 0.7 for every 1 of Quest PharmaTech Inc.'s yearly profit, lower than 98% of Healthcare companies in Canada.
What is Quest PharmaTech Inc.'s return on equity?
Quest PharmaTech Inc. earned 20.0% on its shareholders' money over the last year, higher than 87% of Healthcare companies in Canada.
Does Quest PharmaTech Inc. pay a dividend?
No. Quest PharmaTech Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.